These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 25556547)

  • 1. Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence.
    Andrew AS; Marsit CJ; Schned AR; Seigne JD; Kelsey KT; Moore JH; Perreard L; Karagas MR; Sempere LF
    Int J Cancer; 2015 Sep; 137(5):1158-66. PubMed ID: 25556547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
    Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
    Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
    Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y
    Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-302b regulates cell functions and acts as a potential biomarker to predict recurrence in bladder cancer.
    Li Z; Zhou L; Lin C; Pan X; Xie J; Zhao L; Quan J; Xu J; Guan X; Xu W; Li H; Chen Y; Lai Y
    Life Sci; 2018 Sep; 209():15-23. PubMed ID: 30075175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of microRNA-34a on cell migration and invasion of invasive urothelial bladder carcinoma by targeting Notch1.
    Zhang C; Yao Z; Zhu M; Ma X; Shi T; Li H; Wang B; Ouyang J; Zhang X
    J Huazhong Univ Sci Technolog Med Sci; 2012 Jun; 32(3):375-382. PubMed ID: 22684561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression.
    Tsikrika FD; Avgeris M; Levis PK; Tokas T; Stravodimos K; Scorilas A
    Genes Chromosomes Cancer; 2018 Mar; 57(3):150-161. PubMed ID: 29181884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting progression of bladder urothelial carcinoma using microRNA expression.
    Rosenberg E; Baniel J; Spector Y; Faerman A; Meiri E; Aharonov R; Margel D; Goren Y; Nativ O
    BJU Int; 2013 Nov; 112(7):1027-34. PubMed ID: 23387295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder.
    Li Z; Wang KE; Zhou XL; Zhou J; Ye CH
    Med Sci Monit; 2018 Jan; 24():438-447. PubMed ID: 29358570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircMYLK promotes the growth, migration, invasion, and survival of bladder cancer cells by upregulating CCND3 level via competitively binding to miR-34a.
    Ye W; Chen L; Feng C; Liang T
    Drug Dev Res; 2021 Dec; 82(8):1206-1216. PubMed ID: 34056735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
    Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
    J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.
    Wang S; Li Q; Wang K; Dai Y; Yang J; Xue S; Han F; Zhang Q; Liu J; Wu W
    Clin Transl Oncol; 2013 Oct; 15(10):849-54. PubMed ID: 23408039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
    Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
    Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Characteristics of Bladder Tumor: Increased Gene Expression of MAGE-A6 and MAGE-A11 with Decreased MicroRNA-34a and MicroRNA-125b.
    Aghamajidi A; Ousati Ashtiani Z; Mohsenzadegan M; Tajik N; Ghafoori Yazdi M; Sharifi L; Nowroozi MR
    Iran J Allergy Asthma Immunol; 2022 Oct; 21(5):561-573. PubMed ID: 36341564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder.
    Hashmi AA; Hussain ZF; Irfan M; Khan EY; Faridi N; Naqvi H; Khan A; Edhi MM
    BMC Urol; 2018 Jun; 18(1):59. PubMed ID: 29879970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma.
    Conconi D; Panzeri E; Redaelli S; Bovo G; Volante M; Viganò P; Strada G; Dalprà L; Bentivegna A
    BMC Res Notes; 2012 Oct; 5():607. PubMed ID: 23114535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-34a expression is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
    Cui X; Wu Y; Wang Z; Liu X; Wang S; Qin C
    Tumour Biol; 2015 May; 36(5):3887-93. PubMed ID: 25596083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of KLF4 is associated with urothelial cancer progression and early recurrence.
    Li H; Wang J; Xiao W; Xia D; Lang B; Wang T; Guo X; Hu Z; Ye Z; Xu H
    J Urol; 2014 Feb; 191(2):493-501. PubMed ID: 24018236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and role of miR-34a in bladder cancer.
    Wang W; Li T; Han G; Li Y; Shi LH; Li H
    Indian J Biochem Biophys; 2013 Apr; 50(2):87-92. PubMed ID: 23720881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells.
    Jia AY; Castillo-Martin M; Domingo-Domenech J; Bonal DM; Sánchez-Carbayo M; Silva JM; Cordon-Cardo C
    Am J Pathol; 2013 Apr; 182(4):1171-9. PubMed ID: 23410519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.